1-196258396-A-G
Position:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_198503.5(KCNT2):āc.3009T>Cā(p.Asp1003Asp) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.998 in 1,614,014 control chromosomes in the GnomAD database, including 803,270 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Genomes: š 0.99 ( 74159 hom., cov: 30)
Exomes š: 1.0 ( 729111 hom. )
Consequence
KCNT2
NM_198503.5 synonymous
NM_198503.5 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.951
Genes affected
KCNT2 (HGNC:18866): (potassium sodium-activated channel subfamily T member 2) Enables chloride-activated potassium channel activity. Involved in potassium ion export across plasma membrane. Located in plasma membrane. Implicated in developmental and epileptic encephalopathy 57. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.6).
BP6
Variant 1-196258396-A-G is Benign according to our data. Variant chr1-196258396-A-G is described in ClinVar as [Benign]. Clinvar id is 1229710.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.951 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.993 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KCNT2 | NM_198503.5 | c.3009T>C | p.Asp1003Asp | synonymous_variant | 26/28 | ENST00000294725.14 | NP_940905.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
KCNT2 | ENST00000294725.14 | c.3009T>C | p.Asp1003Asp | synonymous_variant | 26/28 | 1 | NM_198503.5 | ENSP00000294725.8 |
Frequencies
GnomAD3 genomes AF: 0.987 AC: 150092AN: 152068Hom.: 74102 Cov.: 30
GnomAD3 genomes
AF:
AC:
150092
AN:
152068
Hom.:
Cov.:
30
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.997 AC: 250417AN: 251212Hom.: 124827 AF XY: 0.998 AC XY: 135428AN XY: 135748
GnomAD3 exomes
AF:
AC:
250417
AN:
251212
Hom.:
AF XY:
AC XY:
135428
AN XY:
135748
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.999 AC: 1459986AN: 1461828Hom.: 729111 Cov.: 67 AF XY: 0.999 AC XY: 726380AN XY: 727208
GnomAD4 exome
AF:
AC:
1459986
AN:
1461828
Hom.:
Cov.:
67
AF XY:
AC XY:
726380
AN XY:
727208
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.987 AC: 150208AN: 152186Hom.: 74159 Cov.: 30 AF XY: 0.988 AC XY: 73489AN XY: 74406
GnomAD4 genome
AF:
AC:
150208
AN:
152186
Hom.:
Cov.:
30
AF XY:
AC XY:
73489
AN XY:
74406
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
3464
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Apr 13, 2019 | - - |
Developmental and epileptic encephalopathy, 57 Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Aug 19, 2021 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at